Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype: An adaptive component of NK cell- mediated responses

Journal of Experimental Medicine

Volumn 191, Issue 1, 2000, Pages 129-138

  Glas, Richard ^a   Franksson, Lars ^a   Une, Clas ^a   Eloranta, Maija Leena ^b   Öhlén, Claes ^a   Örn, Anders ^a   Kärre, Klas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Activation; Interferon ; MHC class I; Natural killer cell; Tumor

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; EFFECTOR CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERITONEAL CAVITY; PHENOTYPE; PRIORITY JOURNAL; TARGET CELL; TUMOR CELL;

ANIMALS; ANTIGENS; ANTIGENS, SURFACE; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON TYPE II; INTERLEUKIN-12; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED CBA; PHENOTYPE; PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034598369     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.1.129     Document Type: Article

References (68)

1. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187-376.
2. Lamer, L.L. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359-393.
3. Moretta, L., E. Ciccone, M.C. Mingari, R. Biassoni, and A. Moretta. 1994. Human natural killer cells: origin, clonality, specificity, and receptors. Adv. Immunol. 55:341-380.
4. Fan, Q.R., L. Mosyak, C.C. Winter, N. Wagtmann, E.O. Long, and D.C. Wiley. 1997. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors. Nature. 389:96-100.
5. Ljunggren, H.-G., and K. Kärre. 1990. In search of the missing self: MHC molecules and NK recognition. Immunol Today. 11:237-244.
6. Glas, R., K. Sturmhöfel, G.J. Hämmerling, K. Kärro, and H.G. Ljunggren. 1992. Restoration of a tumorigenic phenotype by β2-microglobuhn transfection to EI.-4 mutant cells. J. Exp. Med. 175:843-846.
7. Franksson, L., E. George, S. Powis, G. Butcher, J. Howard, and K. Kärre. 1993. Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene. J. Exp. Med. 177:201-205.
8. Basse, P., R.B. Herberman, U. Nannmark, B.R. Johansson, M. Hokland, K. Wasserman, and R.H. Goldfarb. 1991. Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastasis. J. Exp. Med. 174:479-188.
9. + natural killer cells in tissues from normal and tumor-bearing rats. Cancer Res. 51:4931-4936.
10. Whiteside, T.L., and R.B. Herberman. 1992. Extravasation of antitumor effector cells. Invasion Metastasis. 12:128-146.
11. Fogler, W.E., K. Volker, K.L. McCormick, M. Watanabe, J.R. Ortaldo, and R.H. Wiltrout. 1996. NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM/VLA-4 interaction. J. Immunol. 156:4707-4714.
12. Kurosawa, S., G. Matsuzaki, M. Harada, T. Ando, and K. Nomoto. 1993. Early appearance and activation of natural killer cells in tumor-infiltrating lymphoid cells during tumor development. Eur. J. Immunol. 23:1029-1033.
13. Smyth, M.J., J.M. Kelly, A.G. Baxter, H. Korner, and J.D. Sedgewick. 1998. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the poritoneum. J. Exp. Med. 188:1611-1619.
14. Wiltrout, R.H., B.J. Mathieson, J.E. Talmadge, C.W. Reynolds, S.R. Zhang, R.B. Herberman, and J.R. Ortaldo. 1984. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. J. Exp. Med. 160:1431-1449.
15. Pilaro, A.M., D.D. Taub, K.L. McCormick, U.M. Williams, T.J. Sayers, W.E. Fogler, and R.H. Wiltrout. 1994. TNF-α is a principal cytokine involved in the recruitment of NK cells to liver parenchyma. J. Immunol. 153:333-342.
16. McIntyre, K.W., and R.M. Welsh. 1986. Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection. J. Exp. Med. 164:1667-1681.
17. Natuk, R.J., and R.M. Welsh, 1987. Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication. J. Immunol. 138:877-883.
18. Salazar-Mather, T.P., J.S. Orange, and C.A. Biron. 1998. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell intlannnation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways. J. Exp. Med. 187:1-14.
19. Allavena, P., G. Bianchi, C. Paganin, G. Giardina, and A. Mantovani. 1996. Regulation of adhesion and transendothelial migration ot natural killer cells. Nat. Immunol. 15:107-116.
20. Taub, D.D., TJ. Savers, C.R. Carter, and J.R. Ortaldo. 1995. α and β chemokines induce NK cell migration and enhance NK cell mediated cytolysis. J. Immunol. 155:3877-3888.
21. Maghazachi, A.A. 1991. Tumor necrosis factor-α is chemokinetic for lymphokine-activated killer cells: regulation by cyclic adenosine monophosphate. J. Leukoc. Biol. 49:302-308.
22. Lövik, G., J.T. Vaage, C. Naper, H.H. Benestad, and B. Rolstad. 1995. Recruitment of alloreactive natural killer cells to the rat peritoneum by a transtected cell line secreting rat recombinant interleukin-2. J. Immunol. Methods. 179:59-69.
23. Bancroft, G.J. 1993. The role of natural killer cells in innate resistance to infection. Curr. Opin. Immunol. 5:503-510.
24. Biron, C.A. 1997. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9:24-34.
25. Bukowski, J.F., J.F. Warner, G. Dennert, and R.M. Welsh. 1985. Adoptive transfer studies demonstrating the antiviral effects of natural killer cells in vivo. J. Exp. Med. 161:40-52.
26. Biron, C.A., K.S. Byron, and J.L. Sullivan. 1989. Severe herpes virus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:1731-1735.
27. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178:567-577.
28. Orange, J.S., B. Wang, C. Terhorst, and C.A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045-1056.
29. Bosnia, M.J., and A.M. Carroll. 1991. The SCID mouse mutant: definition, characterization and potential uses. Annu. Rev. Immunol. 9:323-350.
30. Kärre, K., H.-G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defence strategy. Nature. 319:675-678.
31. Ljunggren, H.G., and K. Kärre. 1985. Host resistance directed selectively against H-2-deficient lymphonia variants. Analysis of the mechanism. J. Exp. Med. 162:1745-1759.
32. Powis, S.J., A.R. Townsend, E.V. Deverson, J. Bastin, G.W. Butcher, and J.C. Howard. 1991. Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter. Nature. 354:528-531.
33. Attaya, M., S. Jameson, C.K. Martinez, R. Hermel, C. Aldrich, J. Forman, H.K.F. Lindahl, M.J. Bevan, and J.J. Monaco. 1992. Ham-2 corrects the class I antigen processing defect in RMA-S cells. Nature. 355:647-649.
34. 2-microglobulin restores the IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants. J. Immunol. 145:380-386.
35. Lagoo-Deenadayalan, S., A.S. Lagoo, W.H. Barber, and K.J. Hardy. 1993. A standardized approach to PCR-based semi-quantitation of multiple cytokine gene transcripts from small cell samples. Lymphokine Cytokine Res. 12:59-67.
36. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidiniuin thiocyanite-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
37. Gilliland, G., S. Perrin, K. Blanchard, and H. Bunn. 1990. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 87:2725-2729.
38. Rottenberg, M., L. Sporrong, I. Persson, H. Wigzell, and A. Örn. 1995. Cytokine gene expression during infection of mice lacking CD4 and/or CD8 with Trypanosoma cruzi. Scand. J. Immunol. 41:164-170.
39. Laucella, S., R. Salcedo, E. Castaños-Velez, A. Riarte, E. De Titto, M. Patarroyo, A. Örn, and M. Rottenberg. 1996. Increased expression and secretion of ICAM-1 during experimental infection with Trypanosoma cruzi. Parasite Immunol. 18:227-239.
40. Guevara-Mendoza, O., C. Une, P. Franceschi Carreira, and A. Örn. 1997. Experimental infection of Balb/c mice with Leishmania panamensis and Leishmania Mexicana: induction of early IFN-γ but not IL-4 is associated with the development of cutaneous lesions. Scand. J. Immunol. 46:35-40.
41. Eloranta, M.-L., K. Sandberg and G.V. Alm. 1996. The interferon α/β responses of mice to herpes simplex virus studied at the blood and tissue level in vitro and in vivo. Scand. J. Immunol. 43:356-360.
42. Glas, R., M. Waldenström, P. Höglund, G. Klein, K. Kärre, and H.G. Ljunggren. 1995. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex class I expression on the graft. Cancer Res. 55:1911-1916.
43. Biron, C.A., and R.M. Welsh. 1982. Blastogenesis of natural killer cells during viral infection in vivo. J. Immunol. 129: 2788-2795.
44. Orange, J.S., and C.A. Biron. 1996. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156:1138-1142.
45. Cousens, L.P., R. Peterson, S. Hsu, A. Dorner, J.D. Altman, R. Ahmed, and C.A. Biron. 1999. Two roads diverged: interferon α/β- and interleukin 12-mediated pathways in promoting T cell interferon γ responses during viral infection. J. Exp. Med. 189:1315-1328.
46. Bukowski, J.F., C.A. Biron, and R.M. Welsh. 1983. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus. J Immunol. 131:991-996.
47. Ploegh, H.L. 1998. Viral strategies of immune evasion. Science. 280:248-253.
48. Momburg, F., and S. Koch. 1989. Selective loss of beta 2-microglobulin mRNA in human colon carcinoma. J. Exp. Med. 169:309-314.
49. Restifo, N.P., F. Esquivel, Y. Kawakami, J.W. Yewdell, J.J. Mulé, S.A. Rosenberg, and J.R. Bennink. 1993. Identification of human cancers deficient in antigen processing. J. Exp. Med. 177:265-272.
50. Höglund, P., R. Glas, C. Ohlen, H.-G. Ljunggren, and K. Kärre. 1991. Alteration of the natural killer repertoire in H-2 transgenic mice: specificity of rapid lymphoma clearance determined by the H-2 phenotype of the target. J. Exp. Med. 174:327-334.
51. Whiteside, T.L., N.L. Vujanovic, and R.B. Herberman. 1998. Natural killer cells and tumor therapy. Curr. Top. Microbiol. Immunol. 230:221-244.
52. Schwarz, R.E., N.L. Vujanovic, and J.C. Hiserodt. 1989. Enhanced anti-metastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic. Cancer Res. 49:1441-1446.
53. Yasumura, S., W.C. Lin, H. Hirabayashi, N.L. Vujanovic, R.B. Herberman, and T.L. Whiteside. 1994. Immunotherapy of liver metastases of human gastric carcinoma with IL-2 activated natural killer cells. Cancer Res. 54:3808-3816.
54. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1998. Herpes simplex virus turns off the TAP to evade host immunity. Nature. 375:411-415.
55. Vitale, M., C. Bottino, S. Sivori, L. Sanseverino, R. Castriconi, E. Marcenaro, R. Augugliaro, L. Moretta, and A. Moretta. 1998. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187:2065-2072.
56. Pessino, A., S. Sivori, C. Bottino, A. Malaspina, L. Morelli, L. Moretta, R. Biassoni, and A. Moretta. 1998. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med. 188:953-960.
57. Biassoni, R., A. Pessino, C. Bottino, D. Pende, L. Moretta, and A. Moretta. 1999. The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur. J. Immunol. 29:1014-1020.
58. Helander, T., O. Carpen, O. Turunen, P.E. Kovanen, A. Vaheri, and T. Timonen. 1996. ICAM-2 redistributed by ezrin as a target for killer cells. Nature. 382:265-268.
59. Chambers, B.J., M. Salcedo, and H.G. Ljunggren. 1996. Triggering of a natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity. 5:311-317.
60. Bix, M., N.S. Liao, M. Ziljstra, J. Loring, R. Jaenisch, and D. Raulet. 1991. Rejection of class I-MHC deficient haemopoietic cells by irradiated MHC-matched cells. Nature. 349:329-331.
61. - bone marrow in chimeric mice. Proc. Natl. Acad. Sci. USA 88:10332-10336.
62. Ericsson, P.O., J. Hansson, M. Hohlsten, H.O. Sjögren. J.C. Hiserodt, and G. Hedlund. 1992. In vivo induced allo-reactive natural killer cells. J. Immunol. 149:1504-1509.
63. Brutkiewicz, R.R., S.J. Klaus, and R.M. Welsh. 1992. Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression. Nat. Immun. 11:203-214.
64. Kleijnen, M.F., J.B. Huppa, P. Lucin, S. Mukherjee, H. Farrell, A.E. Campell, U.H. Koszinowski, A.B. Hill, and H.L. Ploegh. 1997. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO (Eur. Mol. Biol. Organ.) J. 16:685-694.
65. Tay, C.H., and R.M. Welsh. 1997. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71:267-275.
66. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297-322.
67. Bancroft, G.J., R.D. Schreiber, E.R. Unanue. 1991. Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol. Rev. 124:5-24.
68. Cosman, D., N. Fanger, and E. Borges. 1999. Human cytomegalovirus, MHC- class I and inhibitory signalling receptors: more questions than answers. Immunol. Rev. 168: 177-185.